MitraClip was designed to spare patients from open-heart surgery by snaking hardware into the heart through a major vein. Its manufacturer, Abbott, said it offered new hope for people severely ill ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical ...

Abbott Laboratories has announced that its implantable heart device, MitraClip, has not been recommended for approval by reviewers at the US Food and Drug Administration. Clinical trials ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

MitraClip® (Abbott Vascular, CA, USA), a new device for transcatheter mitral valve repair, which gained CE mark approval for use in Europe in 2008, is now approved in the USA for use in patients ...

Edwards Lifesciences' Pascal device and its emerging portfolio of transcatheter mitral technologies are likely to put pressure on Abbott's MitraClip franchise over the longer term. Abbott remains ...

In severe cases, surgery can repair or replace the valve. If patients are not candidates for surgery, doctors can implant a clothespin-like device called a MitraClip that helps the valve close ...

The Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) has performed the first successful MitraClip implants on three state-funded patients in Gauteng. The minimally invasive procedure is ...

The MitraClip is a single-size clip device that has been used to treat patients with functional, mixed and degenerative MR. The Clip has a dual arm structure, with grippers above the arms to ...